Fresenius Medical Care (ETR:FME) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?

Fresenius Medical Care AG ( ETR:FME – Get Free Report )’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €38.19 ($39.

37) and traded as high as €44.31 ($45.68).



Fresenius Medical Care shares last traded at €44.16 ($45.53), with a volume of 149,457 shares trading hands.

Fresenius Medical Care Trading Down 0.3 % The company has a quick ratio of 0.80, a current ratio of 1.

46 and a debt-to-equity ratio of 77.56. The business has a 50-day simple moving average of €41.

93 and a 200-day simple moving average of €38.19. The company has a market cap of $12.

96 billion, a PE ratio of 24.40, a price-to-earnings-growth ratio of 0.42 and a beta of 0.

86. About Fresenius Medical Care ( Get Free Report ) Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More Five stocks we like better than Fresenius Medical Care 3 Natural Gas Stocks That Offer Great Dividend Yields Work and Play: Investing in the Rise of Bleisure Travel NYSE Stocks Give Investors a Variety of Quality Options Top Dividend Stocks to Buy Now as Bond Yields Could Lower 3 Healthcare Dividend Stocks to Buy SAP: AI Tailwinds Accelerating Enterprise Cloud Business Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter ..